Sfoglia per Autore "Rouka, E."

AML Survival and In Vivo Progression Is Dependent On beta-Catenin Signaling

Siapati, E. K.; Papadaki, M.; Kozaou, Z.; Rouka, E.; Michali, E.; Gogos, D.; Savvidou, I.; Kyriakou, D. S.; Anagnostopoulos, N. L.; Vassilopoulos, G. (2009)

Computational transcriptomic analysis of claudins in malignant pleural mesothelioma reveals significant correlations in their gene expression patterns

Rouka, E.; Jagirdar, R.; Solenov, E. I.; Hatzoglou, C.; Molyvdas, P. A.; Gourgoulianis, K. I.; Zarogiannis, S. G. (2013)

Neuroblastoma cells negative for CD44 possess tumor-initiating properties

Siapati, E. K.; Rouka, E.; Kyriakou, D.; Vassilopoulos, G. (2011)

CD44 has been linked to favorable prognosis in neuroblastoma and in the present study we investigate if it can be used to prospectively isolate neuroblastoma-initiating cells. To define the cancer-initiating properties of ...

Proliferation and bone marrow engraftment of AML blasts is dependent on beta-catenin signalling

Siapati, E. K.; Papadaki, M.; Kozaou, Z.; Rouka, E.; Michali, E.; Savvidou, I.; Gogos, D.; Kyriakou, D.; Anagnostopoulos, N. I.; Vassilopoulos, G. (2011)

P>B-catenin is the central effector molecule of the canonical Wnt signalling pathway, which controls self-renewal of haematopoietic stem cells. Deregulation of this pathway occurs in various malignancies including myeloid ...